EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unveiling the Diagnostic Value and Potential Therapeutic Targets of Phenylalanine Metabolism in Pancreatic Cancer via Integrated Multi‐Omics and Machine Learning

Xing Liu, Yibin Li, Fangfang Qin, Jianghong Ou iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202603069r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Xing Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Phenylalanine, Machine Learning. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HSTD | Natural Science Foundation of Hunan Province, National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PC) presents a significant global health challenge because of its high mortality rate, highlighting the urgent requirement for effective early diagnostic and therapeutic strategies. This study examined the function of phenylalanine metabolism in PC and developed a high‐accuracy diagnostic model by integrating metabolomics, Mendelian randomization (MR), and machine learning (ML) algorithms. Initially, MR analysis was conducted on 55 plasma metabolites, revealing a significant causal link between phenylalanine and PC. Utilizing GeneCards and public transcriptomic databases, we determined eight differentially expressed genes (DEGs) in PC associated with phenylalanine. Based on these genes, we utilized 12 ML algorithms, totaling 113 combinations, to select the optimal diagnostic model. We applied Shapley Additive exPlanations (SHAP) for feature interpretation and constructed a prognostic nomogram with strong predictive performance by incorporating clinical variables. Furthermore, immune infiltration analysis demonstrated strong connections between these key genes and specific immune cell populations. Based on the SHAP value, we conducted single‐cell RNA sequencing (scRNA‐seq) data and simulated gene knockout analyses using SLC6A14 as the key gene. Drug target prediction‐guided molecular docking and molecular dynamics simulations, focusing on the core gene SLC6A14 , confirmed the high binding stability of candidate compounds. Finally, in vitro cell experiments quantitative real‐time PCR (RT‐qPCR) verified the expression trends of the key genes in PC cell lines. In conclusion, this study successfully developed an ML diagnostic model with high biological interpretability. This analysis aims to identify biomarkers related to phenylalanine metabolism and potential therapeutic drugs for PC, offering new strategies for personalized targeted therapy of PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPhenylalanineMachine LearningHumansMultiomicsMetabolomicsGene Expression Regulation, NeoplasticBiomarkers, Tumor

Stichwörter der Autor:innen

diagnostic markersmachine learningmendelian randomizationmetabolomicspancreatic cancer

Substanzen

PhenylalanineBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Beijing Key Laboratory of Clinical-Based Innovative Drug R&D of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Integrated Chinese and Western Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.

ORCID-Profile: Jianghong Ou

Förderung

  • HSTD | Natural Science Foundation of Hunan Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Liu, X., Li, Y., Qin, F., & Ou, J. (2026). Unveiling the Diagnostic Value and Potential Therapeutic Targets of Phenylalanine Metabolism in Pancreatic Cancer via Integrated Multi‐Omics and Machine Learning. The FASEB Journal. https://doi.org/10.1096/fj.202603069r

Vancouver

Liu X, Li Y, Qin F, Ou J. Unveiling the Diagnostic Value and Potential Therapeutic Targets of Phenylalanine Metabolism in Pancreatic Cancer via Integrated Multi‐Omics and Machine Learning. The FASEB Journal. 2026. doi:10.1096/fj.202603069r

BibTeX
@article{Liu2026,
  author = {Liu, Xing and Li, Yibin and Qin, Fangfang and Ou, Jianghong},
  title = {Unveiling the Diagnostic Value and Potential Therapeutic Targets of Phenylalanine Metabolism in Pancreatic Cancer via Integrated Multi‐Omics and Machine Learning},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202603069r}
}
Kostenlos starten →